Coloplast A/S – Interim Financial Report, 9M 2023/24
Coloplast A/S 9M 2023/24Interim financial results, 9M 2023/241 October 2023 – 30 June 2024 Coloplast delivered 8% organic growth and an EBIT margin1) of 27% in Q3, with 11% growth in absolute EBIT1). Reported revenue in DKK grew 13% which includes 4%-points contribution from Kerecis (underlying growth of around 35%). Organic growth rates by business